Systems for the detection and delivery of neurochemical and electrical signals for functional restoration

US10441791B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10441791-B2
Application numberUS-201816023964-A
CountryUS
Kind codeB2
Filing dateJun 29, 2018
Priority dateJan 9, 2013
Publication dateOct 15, 2019
Grant dateOct 15, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This document provides methods and materials involved in detecting and delivering neurochemical signals, electrophysiological signals, ions, or combinations thereof within a mammal. For example, systems that can include one or more implantable devices containing probes configured to detect neurochemical signals (e.g., neurotransmitter concentrations), electrical signals, ions, or combinations thereof and one or more implantable devices containing electrodes and/or microfluidic delivery components configured to deliver neurochemical signals (e.g., neurotransmitters), electrical signals, ions, or combinations thereof to one or more locations within a mammal are provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: detecting, using one or more probes of a first implantable device located within a first region of a brain of a mammal, first neurochemical signals that indicate concentrations of one or more neurotransmitters within said first region of said brain or first electrical signals that indicate electrical activity of said first region of said brain; telemetering, from a first control unit of said first implantable device and to a second control unit of a second implantable device that is located proximal to a targeted nerve tissue downstream of a damaged or severed nerve tissue of said mammal outside of said brain of said mammal, first information about said first neurochemical signals or about said first electrical signals; receiving, by said second control unit of said second implantable device, said first information about said first neurochemical signals or about said first electrical signals; delivering, using one or more electrodes of said second implantable device, electrical stimulation to said targeted nerve tissue based on said first information about said first neurochemical signals; detecting, using one or more probes of said second implantable device, second neurochemical signals that indicate concentrations of one or more neurotransmitters within a region proximal to said targeted nerve tissue or second electrical signals that indicate electrical activity of said region proximal to said targeted nerve tissue; telemetering, from said second control unit of said second implantable device and to a third control unit of a third implantable device that is located within a second region of said brain of said mammal, second information about said second neurochemical signals or about said second electrical signals, wherein said second region is different from said first region of said brain of said mammal; receiving, by said third control unit of said third implantable device, said second information about said second neurochemical signals or about said second electrical signals; and delivering, using one or more electrodes or one or more microfluidic delivery components of said third implantable device, electrical stimulation or one or more neurochemicals to said second region of said brain of said mammal based on said second information about said second neurochemical signals or about said second electrical signals. 2. The method of claim 1 , wherein: said first information that is telemetered from said first control unit of said first implantable device comprises a first delivery signal profile, and said second information that is telemetered from said second control unit of said second implantable device comprises a second delivery signal profile; and said second implantable device is configured to deliver electrical stimulation to said targeted nerve tissue according to said first delivery signal profile, and said third implantable device is configured to deliver electrical stimulation or neurochemicals to said second region of said brain according to said second delivery signal profile. 3. The method of claim 1 , wherein: telemetering said first information from said first control unit of said first implantable device to said second control unit of said second implantable device comprises transmitting said first information from said first control unit to said second control unit indirectly via a processing unit that is separate from each of said first control unit, said control unit, and said third control unit; and telemetering said second information from said second control unit of said second implantable device to said third control unit of said third implantable device comprises transmitting said second information from said second control unit to said third control unit indirectly via said processing unit. 4. The method of claim 3 , wherein said processing unit is configured to: determine a first delivery signal profile based on said first information from said first implantable device, and to telemeter said first delivery signal profile to said second implantable device; and determine a second delivery signal profile based on said second information from said second implantable device, and to telemeter said second delivery signal profile to said second implantable device. 5. The method of claim 1 , wherein said second implantable device is configured to be located within a limb, a diaphragm, a genital region, a bladder, a vascular system, or facial tissue of said mammal. 6. The method of claim 1 , wherein said second implantable device is configured to be located in a spinal cord region of said mammal. 7. The method of claim 1 , wherein communication of biological signals between said brain of said mammal and said targeted nerve tissue is impaired as a result of said damaged or severed nerve tissue, wherein said system is arranged to at least partially restore communication between said brain of said mammal and said targeted nerve tissue. 8. The method of claim 1 , wherein said first implantable device comprises a sensor that is configured to detect different ones of multiple neurochemicals within said first region of said brain by applying electrical signals with different voltage ramps within said first region of said brain. 9. The method of claim 1 , wherein delivering one or more neurochemicals to said second region of said brain of said mammal comprises administering at least one of adenosine, serotonin, or norepinephrine to said second region of said brain. 10. The method of claim 1 , comprising detecting, using said one or more probes of said first implantable device, said first neurochemical signals that indicate concentrations of said one or more neurotransmitters within said first region of said brain of said mammal. 11. The method of claim 1 , comprising detecting, using said one or more probes of said first implantable device, said first electrical signals that indicate electrical activity of said first region of said brain. 12. The method of claim 1 , comprising delivering, using said one or more electrodes of said third implantable device, electrical stimulation to said second region of said brain of said mammal based on said second information. 13. The method of claim 1 , comprising delivering, using said one or more microfluidic delivery components of said third implantable device, said one or more neurochemicals to said second region of said brain of said mammal based on said second information. 14. A system comprising: a first implantable device comprising (i) a first control unit configured to provide wireless communication capabilities for said first implantable device and (ii) a first probe configured to detect, within a first region of a brain of a mammal, at least one of electrical signals within said first region of said brain or neurochemical signals that indicate concentrations of one or more neurotransmitters within said first region of said brain; a second implantable device comprising (i) a second control unit configured to provide wireless communication capabilities for said second implantable device, (ii) a first electrode configured to deliver electrical stimulation to targeted nerve tissue that is located outside of said brain and downstream of damaged or severed nerve tissue of said mammal and (iii) a second probe configured to detect neurochemical signals that indicate concentrations of one or more neurotransmitters within a region proximal to said targeted nerve tissue; and a third implantable device comprising (i) a third control unit configured to provide wireless communication capabilities for said third implantable device and (ii) a

Assignees

Inventors

Classifications

  • A61N1/0534Primary

    Electrodes for deep brain stimulation · CPC title

  • with automatic adjustment · CPC title

  • Spinal or peripheral nerve electrodes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10441791B2 cover?
This document provides methods and materials involved in detecting and delivering neurochemical signals, electrophysiological signals, ions, or combinations thereof within a mammal. For example, systems that can include one or more implantable devices containing probes configured to detect neurochemical signals (e.g., neurotransmitter concentrations), electrical signals, ions, or combinations t…
Who is the assignee on this patent?
Mayo Found Medical Education & Res
What technology area does this patent fall under?
Primary CPC classification A61N1/0534. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).